StockData
Apnimed, Inc. logo

Apnimed, Inc. (APMD) stock

APMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026
$17.80+1.52 (+9.34%)

Close on Nov 17, 2026Market cap $85.47MP/E –Yield –

Apnimed EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

No ev/ebitda figures for Apnimed

Apnimed has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Apnimed figures

See a number that looks wrong?